Image Analysis | Tissuepathology.com

Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite

Erica Goodpaster — Wed, 05 Aug 2026 13:12:53 +0000

From the Aiforia blog: In modern clinical pathology, adopting artificial intelligence (AI) is no longer just about algorithm accuracy. A key success factor is seamless workflow integration. Pathology departments manage high sample volumes under strict turnaround times, with vendor lock-in and fragmented software as major obstacles to scaling their digital pathology workflows. Last June, at […]

The post Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite first appeared on Tissuepathology.com.

Pathomation: Digital Pathology API & SDK: Simplifying integration with Pathomation

Erica Goodpaster — Tue, 04 Aug 2026 13:19:52 +0000

From the Pathomation blog: Modern digital pathology software must go far beyond simple image viewing. Today’s solutions need to integrate seamlessly with laboratory systems, research platforms, AI pipelines, and web applications—while remaining scalable, secure, and high‑performance. Pathomation’s Digital Pathology API, SDKs, and plugins are designed specifically to meet these needs. By abstracting away the complexity […]

The post Pathomation: Digital Pathology API & SDK: Simplifying integration with Pathomation first appeared on Tissuepathology.com.

Aiforia lands EU financing to develop AI-powered cancer detection

Erica Goodpaster — Mon, 03 Aug 2026 11:08:05 +0000

EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Supported under the European Commission’s InvestEU programme, the financing will accelerate Aiforia’s product development and boost its commercial operations. Aiforia’s deep learning artificial intelligence (AI) solutions can revolutionise diagnostic capabilities in […]

The post Aiforia lands EU financing to develop AI-powered cancer detection first appeared on Tissuepathology.com.

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

Erica Goodpaster — Fri, 31 Jul 2026 11:15:06 +0000

Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis. Antibody-drug conjugates (ADC) have emerged as one of the most promising classes of precision oncology […]

The post Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development first appeared on Tissuepathology.com.

Indica Labs: Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI

Erica Goodpaster — Thu, 30 Jul 2026 11:51:49 +0000

The latest from the Indica Labs Blog Automated biomarker scoring for breast cancer pathology just got smarter. The latest HALO Breast IHC AI release introduces new features designed to remove the remaining manual steps from HER2, ER, PR, and Ki67 workflow, delivering a true zero-click analysis experience from whole slide image to a scored result. […]

The post Indica Labs: Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI first appeared on Tissuepathology.com.

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis

Erica Goodpaster — Wed, 29 Jul 2026 12:34:01 +0000

Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ […]

The post Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis first appeared on Tissuepathology.com.